Scaling Oncology NGS for Biomarker-Ready Translational Research

Translational oncology teams need NGS workflows that deliver trustworthy biomarker data, scale across growing studies and support future clinical decision-making. However, many labs still rely on manual library preparation workflows that increase hands-on time, introduce variability and make standardization across sites and operators difficult.

In this webinar, experts from Integrated DNA Technologies (IDT) and Beckman Coulter Life Sciences will discuss how Archer FUSIONPlex-HT (FP) and VARIANTPlex-HT (VP) assays, automated on the Biomek i3 Benchtop Liquid Handler can help address these challenges. Attendees will see how a walkaway, medium-throughput workflow can reduce hands-on time while maintaining comparable library quality and concordant expected fusion and variant detection relative to manual preparation.

Learning Objectives:

Understand how automation can improve reproducibility and confidence in oncology biomarker workflows
Learn how the Archer FP and VP protocols on the Biomek i3 can reduce hands-on time while maintaining comparable performance to manual workflows
Identify ways to standardize and scale targeted NGS workflows for translational research